For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of cancer like HPV. But what if a vaccine could treat cancer that already exists? IO Biotech is making significant strides under the leadership of Dr. Qasim Ahmad, Chief Medical Officer. At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, he highlighted the company’s groundbreaking work on a new class of therapeutic cancer vaccines. These innovative vaccines are designed to train the immune system to directly combat tumors.